Related Experiment Video
Updated: Jun 16, 2026

13:03
Protocol for Mosquito Rearing (A. gambiae)
Published on: July 4, 2007
The Multilateral Initiative on Malaria: looking back and looking ahead
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA. lmiller@niaid.nih.gov
Trends in Parasitology
|January 26, 2010
Summary
The Multilateral Initiative on Malaria (MIM) remains crucial for supporting African scientists in leading their own malaria research and training. Increased funding has not diminished the need for MIM
Area of Science:
- Global Health
- Medical Research
- African Health Systems
Background:
- The Multilateral Initiative on Malaria (MIM) was established in 1997.
- MIM aimed to ensure African scientists had equal decision-making power in malaria research within Africa.
- Significant increases in malaria research funding from governments and foundations have occurred since MIM's inception.
Purpose of the Study:
- To evaluate the continued relevance and necessity of the Multilateral Initiative on Malaria (MIM) in the current research funding landscape.
- To determine if MIM's objectives are still pertinent given the increased financial support for malaria research.
Main Methods:
- This study is a conceptual analysis and review of the role of MIM.
- The assessment considers the evolution of malaria research funding and African scientific leadership.
Main Results:
- Despite increased funding, a distinct need for MIM persists.
- MIM's unique role in supporting investigator-initiated research by African scientists is highlighted.
Conclusions:
- The Multilateral Initiative on Malaria (MIM) is still essential.
- MIM is vital for fostering independent, African-led research and training initiatives in malaria control and elimination efforts.
Related Concept Videos
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...

